Francisco J. Esteva

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Francisco J. Esteva
Mar 11, 2025, 08:18 | Blog
Francisco J. Esteva: A home away from home for cancer patients
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Feb 27, 2025, 11:33 | Science
Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Feb 22, 2025, 05:18 | Blog
Francisco J. Esteva: The clinical applications of PARPi across various cancers
Francisco J. Esteva, Professor of Medicine at the Zucker School of Medicine, posted on LinkedIn…
Feb 20, 2025, 07:40 | Science
Francisco J. Esteva: What should be the primary endpoint for FDA registration trials in early-stage breast cancer?
Francisco J. Esteva, Professor of Medicine at the Zucker School of Medicine, shared an article…
Jan 21, 2025, 08:57 | Blog
Francisco J. Esteva: The ACS Facts and Figures 2025 is the go-to report for cancer statistics in the US
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jan 19, 2025, 13:09 | Blog
Francisco J. Esteva: The critical need for continued innovation in managing low-risk breast cancers effectively
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Jan 15, 2025, 13:30 | Blog
Francisco J. Esteva: FDA has mandated that all mammography facilities include breast density information in their reports
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital…
Dec 29, 2024, 09:19 | Science
Francisco J. Esteva: Nearly 6 Million Cancer Deaths Prevented—Here’s How
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Dec 19, 2024, 16:42 | Blog
Registration for the 2025 ASCO Annual Meeting is officially open!
American Society of Clinical Oncology (ASCO) made the following post on LinkedIn: “Registration for the 2025…
Dec 18, 2024, 13:14 | Insight
Francisco J. Esteva: Exploring the latest advancements in breast cancer research and treatment
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 16, 2024, 08:20 | Blog
Francisco J. Esteva: Addressing gaps in real-world oncology care through data studies
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 15, 2024, 08:59 | Blog
Francisco J. Esteva: The role of immunotherapy in early-stage triple-negative breast cancer
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 14, 2024, 13:10 | Blog
Francisco J. Esteva: The importance of individualized treatment planning based on tumor biology and size
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division of…
Dec 14, 2024, 07:35 | Blog
Francisco J. Esteva: Evolving nature of HER2 biomarkers
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 13, 2024, 22:20 | Blog
Francisco J. Esteva: The role of palbociclib in improving outcomes for patients with metastatic breast cancer
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Dec 13, 2024, 16:50 | Insight
Francisco J. Esteva: The clinical validation results of Ataraxis Breast at SABCS24
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Dec 13, 2024, 16:21 | Blog
Francisco J. Esteva: Kicking off SABCS24 with the amazing breast cancer team from Northwell Cancer Institute
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Dec 8, 2024, 10:44 | Blog
2025's Most Promising Cancer Therapies Explained by Francisco J. Esteva
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Nov 30, 2024, 18:50 | Blog
Francisco J. Esteva: How the MammaPrint test could identify patients who benefit from varying durations of EET
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Nov 24, 2024, 13:25 | Insight
Francisco J. Esteva: What if the cells you thought were only in cancer could also be in healthy tissue?
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Nov 23, 2024, 13:00 | Blog
Francisco J. Esteva: The role of medications like Ozempic in promoting health alongside lifestyle changes
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Nov 16, 2024, 11:27 | Blog
Francisco J. Esteva: Katalin Karikó’s groundbreaking work on nucleoside base modifications revolutionized medicine
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Nov 14, 2024, 13:37 | Blog
Francisco J. Esteva: Can we truly trust AI in Cancer Care?
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Nov 8, 2024, 15:37 | Blog
Francisco J. Esteva: Will AI replace Oncologists?
Francisco J. Esteva, Director of Breast Cancer Translational Research for the Northwell Health Cancer Institute,…
Nov 1, 2024, 14:35 | Blog
Francisco J. Esteva: The standard of care for hormone receptor-positive, HER2-negative metastatic breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a post on…
Oct 25, 2024, 19:14 | Blog
Next-Generation HER2-Targeted ADC's in Breast Cancer - Cancers MDPI
Cancers MDPI shared a post on LinkedIn: ''Check out the Editor's Choice Article 'Next-Generation HER2-Targeted…
Oct 24, 2024, 15:31 | Blog
Francisco Esteva: Breast MRI awareness varies across USA, Europe, and China
Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Oct 9, 2024, 11:42 | Blog
Francisco J. Esteva: Rising breast cancer rates and disparities among women under 50
Francisco J. Esteva, Director at Breast Cancer Translational Research, shared a post on LinkedIn: “Breast…
Oct 4, 2024, 15:10 | Blog
Francisco J. Esteva: The way we approach HER2 testing for breast cancer is changing
Francisco J. Esteva, Director at Breast Cancer Translational Research, shared a post on LinkedIn: "Progress…
Sep 29, 2024, 12:53 | Blog
31 Hispanic and Latino leaders to know in 2024
Becker's released a list honoring Hispanic and Latino healthcare leaders. Diverse leadership in healthcare enhanced…
Sep 28, 2024, 14:16 | Blog
Francisco J. Esteva: Honored to be included in Becker's Hospital Review's '63 Hispanic and Latino Leaders to Know 2024'
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on…
Sep 22, 2024, 17:46 | Blog
Francisco J. Esteva: KEYNOTE-522 Trial Shows Pembrolizumab Boosts Survival in Triple-Negative Breast Cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, posted the…
Sep 18, 2024, 16:29 | Blog
Francisco J. Esteva: A new era in personalized medicine for high-risk stage 2/3 breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Sep 18, 2024, 12:52 | Blog
Francisco Esteva: Universal genetic testing may not be as impactful as previously thought
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology, Lenox Hill Hospital, posted the following…
Sep 10, 2024, 13:50 | Blog
Francisco J. Esteva: The importance of improving ctDNA methodologies
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 9, 2024, 17:35 | Insight
Francisco J. Esteva: Combining cellular therapy with oncolytic virotherapy for stronger anti-tumor response
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 4, 2024, 14:39 | Blog
Impact of care density on breast cancer treatment timelines
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Sep 2, 2024, 18:04 | Insight
Francisco J. Esteva: Lifestyle choices impact cancer risk!
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 2, 2024, 03:56 | Insight
Francisco J. Esteva: The critical role of regular screenings in improving breast cancer outcomes
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Aug 25, 2024, 16:32 | Blog
Francisco J. Esteva: Capivasertib combined with fulvestrant offers new hope in breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Aug 21, 2024, 17:42 | Blog
Francisco J. Esteva: Where in the world are the largest gaps in female specific cancers?
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Aug 19, 2024, 05:25 | Blog
Francisco J. Esteva: The potential of integrating physical activity into treatment protocols
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Aug 15, 2024, 04:24 | Blog
Effectiveness of scalp cooling programs for chemotherapy-induced alopecia
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Aug 12, 2024, 12:38 | Insight
Francisco J. Esteva: The NeoSTEEP initiative
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Aug 6, 2024, 18:58 | Blog
Francisco J. Esteva: MRI surveillance significantly reduces breast cancer mortality in women with BRCA1 or BRCA2 mutation
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Jun 20, 2024, 14:20 | Blog
Francisco J. Esteva: Breast cancer survivors are at higher risk of heart failure especially if they receive anthracycline-based chemotherapy
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Jun 5, 2024, 05:51 | Blog
Francisco J. Esteva: Congratulations to Giuseppe Curigliano for the presentation of the DESTINY-Breast06 trial at ASCO24
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 3, 2024, 23:54 | Insight
Francisco J. Esteva: Dr. King's Career Development and Dr. Boisclair's Young Investigator Awards are well-deserved
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
May 24, 2024, 00:58 | Blog
Francisco J. Esteva on the DESTINY-Breast06 trial
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
May 5, 2024, 07:02 | Blog
Francisco J. Esteva: 5 common myths or misconceptions about cancer immunotherapy
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a…
Mar 25, 2024, 07:01 | Opinion
Francisco J. Esteva: It is important to understand the treatment of early breast cancer must be individualized
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jan 14, 2024, 15:07 | Insight
Francisco J. Esteva: The evolution of HER2 as a pivotal biomarker in breast cancer diagnosis and treatment is a fascinating story
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
All: 52 Posts: 1 - 100
Special Coverage